0.75
-6.48%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Predilife
Its shares trade on Euronext Paris under the ticker ALPRE.PA. It has been listed since 21 December 2018. In the fiscal year to 31 December 2025, it reported revenue of €1.1m and a net loss of €3.5m. At that date it held total assets of €1.8m and shareholders' equity of −€6.9m.
Predilife SA operates as a medical technology company. The company is headquartered in Villejuif, Ile-De-France. The company went IPO on 2018-12-21. The firm operates mainly in the field of oncology. Predilife offers MammoRisk, which is a predictive breast cancer test that combines medical imaging thanks to a proprietary software, DenSeeMammo, Big Data and statistics through a scoring tool and genetic profiles via a polygenic risk score (PRS). The image is analysed in order to extract the breast density and the first breast cancer risk factor. In addition, The technology used by MammoRisk makes it possible to evaluate from a database of individuals tracked over time, the risks of an individual to develop cancer compared to the fate of his/her closest neighbors through a database of a number of American and French women.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 21 Dec 2018
- Employees
- 8
- Website
- predilife.com ↗
Leadership
Pay as last reported
- Mr. Stephane RagusaChairman of the Board, Chief Executive Officer, since 2018€150,000
- Mr. Antoine BricardDirector€5,000
- Ms. Ombline De VilleleIndependent Director€5,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Predilife SA possesses several strengths that contribute to its success in the market. Firstly, the company benefits from a strong brand reputation, built over years of delivering reliable healthcare solutions. This establishes trust and credibility among customers and partners.
- Additionally, Predilife SA is known for its advanced technological infrastructure, enabling the development and delivery of cutting-edge predictive medicine solutions. This provides a competitive advantage and positions the company at the forefront of the industry.
- Furthermore, the company boasts a highly skilled and experienced workforce. The expertise and knowledge of its professionals contribute to the effective execution of operations and the development of innovative products.
Weaknesses
- Despite its strengths, Predilife SA also faces certain weaknesses that should be addressed. One of the primary weaknesses is the limited geographic presence of the company. Predilife SA currently operates in a few select markets, which poses a risk in terms of relying on a limited customer base.
- In addition, the company's heavy dependence on external suppliers for key components may lead to potential supply chain disruptions. This vulnerability could impact production and customer satisfaction in the event of supplier issues.
Opportunities
- Predilife SA has several opportunities it can leverage for future growth. One significant opportunity lies in expanding its market reach to untapped regions or countries. This would enable the company to access new customer segments and increase revenue.
- Furthermore, the growing global focus on personalized medicine and preventive healthcare presents an opportunity for Predilife SA to develop and market innovative predictive medicine solutions. By capitalizing on this trend, the company can gain a competitive edge and strengthen its market position.
Threats
- In the face of opportunities, Predilife SA also encounters threats that could hinder its progress. One of the major threats is intense market competition. Competitors with similar products and services may offer lower prices or superior features, potentially leading to market share erosion.
- Additionally, regulatory changes or stringent international standards in the healthcare industry may pose compliance challenges for Predilife SA. Adapting to evolving regulations and maintaining compliance can be costly and time-consuming.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.